StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

EVHBearishEarningsnews
Materiality pending

Evolent Health (EVH) Q1 Earnings and Revenues Top Estimates

May 9, 2024, 7:53 PM EDT1 sourcesAI-analyzed

AI summary

What happened, with direct paths to the underlying reporting

- EVH quarterly earnings: $0.34/share, beats estimates by 61.90%, revenues surpass estimates by 6.33%. - Company has beaten consensus EPS estimates four times in the past four quarters. - Future stock performance will depend on management's commentary on earnings call. - EVH shares down 17.4% YTD, underperforming S&P 500's gain of 8.8%. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings

  • EVH quarterly earnings: $0.34/share, beats estimates by 61.90%, revenues surpass estimates by 6.33%.
  • Company has beaten consensus EPS estimates four times in the past four quarters.
  • Future stock performance will depend on management's commentary on earnings call.
  • EVH shares down 17.4% YTD, underperforming S&P 500's gain of 8.8%.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.